Alpha IVF Group Bhd

Alpha IVF Group Bhd EBITDA per Share

The EBITDA per Share of Alpha IVF Group Bhd (ALPHA.KL) as of Oct 29, 2026 is 0.01 MYR. In the previous year, EBITDA per Share was 0.01 MYR — a change of -1.44% (lower).

EBITDA per Share

0.01MYR

YoY

-1.44%

Last updated:

EBITDA per Share of Alpha IVF Group Bhd is 2026 0.01 MYR. EBITDA per Share of Alpha IVF Group Bhd was 2025 0.01 MYR. It decreases by -1.44% lower compared to the previous year.

The Alpha IVF Group Bhd EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2020
0.00 MYR
Jan 1, 2021
0.00 MYR
Jan 1, 2022
0.01 MYR
Jan 1, 2023
0.01 MYR
Jan 1, 2024
0.01 MYR
Jan 1, 2025
0.01 MYR
Jan 1, 2026
0.01 MYR
The Alpha IVF Group Bhd EBITDA per Share history
YEAREBITDA per ShareYoY
0.01MYR-1.44%
0.01MYR-2.81%
0.01MYR+30.88%
0.01MYR+77.24%
0.01MYR+112.69%
0.00MYR+229.34%
0.00MYR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alpha IVF Group Bhd Stock analysis

What does Alpha IVF Group Bhd do? Alpha IVF Group Bhd generates revenue through its comprehensive fertility services, including assisted reproductive technologies (ART) and related medical treatments. The company operates specialist fertility care centers across Malaysia, offering services such as fertility assessment, diagnostics, testing, monitoring, preconception care, and counseling. Medical specialists in obstetrics and gynecology provide ART procedures and prescribe fertility drugs, forming the core of the company's service offerings. The primary customers are individuals or couples seeking solutions for infertility challenges, with the company's focus on technology-driven fertility care and research. The firm's business model centers on delivering end-to-end fertility solutions through its network of specialized centers. ART encompasses a range of medical technologies and laboratory procedures designed to assist infertility, supported by the company's in-house labs and technology infrastructure. Revenue is derived from the provision of these services, including diagnostics, monitoring, and prescription of fertility-related medications. The company targets patients requiring advanced fertility treatments, leveraging its expertise in obstetrics and gynecology to address infertility through both medical and technological approaches. Alpha IVF Group Bhd differentiates itself through its integrated approach to fertility care, combining medical expertise with laboratory technology. The company's services are structured around the needs of patients facing infertility, offering a full spectrum of support from initial assessment to ongoing care. By focusing on ART and related services, the company positions itself as a provider of specialized fertility solutions within the healthcare sector, with revenue streams directly tied to the delivery of these services to its patient base. Alpha IVF Group Bhd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alpha IVF Group Bhd stock

EBITDA per Share of Alpha IVF Group Bhd is 0.01 MYR in 2026.

EBITDA per Share of Alpha IVF Group Bhd changed from 0.01 MYR to 0.01 MYR, representing a -1.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Alpha IVF Group Bhd since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Alpha IVF Group Bhd

All Key Metrics — Alpha IVF Group Bhd